The most effective therapeutic measure to correct uremic anemia is generally aggressive treatment with artificial recombinant erythropoietin. Artificial erythropoietin is more effective in the treatment of renal anemia and is generally equally effective when administered intravenously or subcutaneously. However, subcutaneous administration is more effective than intravenous administration, and it can prolong the duration of the effective drug concentration in the body and save the cost of treatment, and subcutaneous injection is slightly more painful than intravenous injection. Therefore, subcutaneous injections should be actively used to correct renal anemia. Along with the use of artificial erythropoietin, assessment of iron and folic acid in patients should be carried out, and if necessary, therapeutic measures such as iron supplementation and folic acid supplementation can be used to enhance the therapeutic measures to correct anemia, which is more effective in the treatment of renal anemia in patients.